(Reuters) - European shares slipped on Friday after a rally in the previous session spurred by U.S. Federal Reserve's ...

All major European markets were trading lower, except Spain’s that edged up 0.1% ... European Medicines Agency backed the use ...

Stock futures edged lower as the dust settled after Thursday's rally, and bond yields traded just shy of two week highs. Investors will see option contracts tied to more than $5 trillion in tradeable ...

Singapore has risen to the top of a ranking of the world’s strongest passports, knocking Spain off the top spot. Despite that blow for the country, European nations - including Spain ...

Some people may be eligible for Medicare coverage for Wegovy if they meet medical criteria for heart disease risk. However, Medicare does not cover medications that are strictly for weight management.

(Reuters) -The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with obesity, the Danish drugmaker said on Thursday. This marks ...

(RTTNews) - Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of the Wegovy ...

New Yorkers considering taking weight-loss drugs like Wegovy and Ozempic must navigate complex rules for public and private health insurance plans. At the same time, state lawmakers are debating ...

A small clinical trial suggests that a duo of drugs can extend survival for people battling advanced kidney cancer.

Have a great day, everyone. … Hims & Hers Health plans to sell compounded versions of Novo Nordisk’s popular weight loss drug Wegovy to patients in certain professions for $99 a month ...

NEW YORK (Reuters) - U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular weight-loss drug Wegovy to patients in certain ...